INTRACTABLE HEMATURIA IN BLADDER CANCER WITH UNILATERAL HIGH GRADE VESICOURETERAL REFLUX: A CONSERVATIVE APPROACH USING INTRAVESICAL FORMALDEHYDE INSTILLATION
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Objective: This study aims to report a case of intractable hematuria in a patient with bladder cancer after radiotherapy. Case(s) Presentation: This case reported a 41-year-old male with urothelial carcinoma of bladder who came to our hospital hematuria symptoms that arised four months after radiotherapy session. The patient was admitted several times with intractable hematuria along with low levels of hemoglobin, and diagnosed with cystitis radiation. Discussion: Voiding cystourethrogram (VCUG) showed unilateral high grade vesicoureteral reflux (VUR). The patient showed no sign of improvement after transarterial embolization (TAE), radiation, and high-dose of steroids. However, the symptoms finally resoluted after formaldehyde instillation. Conclusion: Patients with a history of bladder cancer who develop hematuria after radiotherapy should be evaluated promptly to exclude the possibility of recurrent disease. The administration of formaldehyde instillation could lower the symptoms of hematuria and maintain hemoglobin levels. Keywords: Intractabel hematuria, formaldehyde, bladder cancer.
##plugins.themes.bootstrap3.article.details##
Intractable hematuria, Formaldehyde, Bladder Cancer
Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiology of Bladder Cancer. Med Sci (Basel). 2020 Mar 13;8(1):15. doi: 10.3390/medsci8010015. PMID: 32183076; PMCID: PMC7151633.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur Urol. 2017 Jan;71(1):96-108. doi: 10.1016/j.eururo.2016.06.010. Epub 2016 Jun 28. PMID: 27370177.
Lavdaniti M, Zyga S. Quality of Life in Elderly Bladder Cancer Patients Following a Cystectomy. Adv Exp Med Biol. 2017;989:297-300. doi: 10.1007/978-3-319-57348-9_28. PMID: 28971439.
Pham A, Ballas LK. Trimodality therapy for bladder cancer: modern management and future directions. Curr Opin Urol. 2019 May;29(3):210-215. doi: 10.1097/MOU.0000000000000601. PMID: 30855374; PMCID: PMC7440298.
National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology – Bladder Cancer. 2023. Feb 1;9.
Aragon-Ching JB, Werntz RP, Zietman AL, Steinberg GD. Multidisciplinary Management of Muscle-Invasive Bladder Cancer: Current Challenges and Future Directions. Am Soc Clin Oncol Educ Book. 2018 May 23;38:307-318. doi: 10.1200/EDBK_201227. PMID: 30231340.
Payne H, Adamson A, Bahl A, Borwell J, Dodds D, Heath C, Huddart R, McMenemin R, Patel P, Peters JL, Thompson A. Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges. BJU Int. 2013 Nov;112(7):885-97. doi: 10.1111/bju.12291. PMID: 24000900; PMCID: PMC4155867.
Alesawi AM, El-Hakim A, Zorn KC, Saad F. Radiation-induced hemorrhagic cystitis. Curr Opin Support Palliat Care. 2014 Sep;8(3):235-40. doi: 10.1097/SPC.0000000000000073. PMID: 25004179.
Abt D, Bywater M, Engeler DS, Schmid HP. Therapeutic options for intractable hematuria in advanced bladder cancer. Int J Urol. 2013 Jul;20(7):651-60. doi: 10.1111/iju.12113. Epub 2013 Feb 6. PMID: 23387805.
Ghahestani SM, Shakhssalim N. Palliative treatment of intractable hematuria in context of advanced bladder cancer: a systematic review. Urol J. 2009 Summer;6(3):149-56. PMID: 19711266.
Sarnak MJ, Long J, King AJ. Intravesicular formaldehyde instillation and renal complications. Clin Nephrol. 1999 Feb;51(2):122-5. PMID: 10069648.